Veracyte, Inc.
VCYT
Hisse Senetlerindeki Sıralama
#4231
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Hisse Fiyatı
$46.05
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$3.70B
Değişim (1 gün)
2.81%
Değişim (1 yıl)
32.51%
Ülke
US
Ticaret Veracyte, Inc. (VCYT)
Kategori
Healthcare
Veracyte, Inc. (VCYT) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $44.47 - 2026-10-01
Gün sonu en düşük fiyat: $12.82 - 2013-10-01
Gün sonu en düşük fiyat: $12.82 - 2013-10-01
Veracyte, Inc. için hisse fiyatı geçmişi: 2013 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | -2.90% |
| 2025 | 3.85% |
| 2024 | 55.02% |
| 2023 | 1.26% |
| 2022 | -33.63% |
| 2021 | -25.42% |
| 2020 | 88.25% |
| 2019 | 137.21% |
| 2018 | 87.23% |
| 2017 | -13.42% |
| 2016 | 5.54% |
| 2015 | -8.13% |
| 2014 | -43.76% |
| 2013 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
